Home › Funds › Millennium Management › BCLI
Millennium Management position in BCLI
BRAINSTORM CELL THERAPEUTICS
Latest position (Q3 2023)175.50K sh
Reported value held$35.12K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 150.33K | $496.00K | New |
| Q4 2021 | 150.17K | $601.00K | Hold |
| Q1 2022 | 141.25K | $475.00K | Reduce |
| Q2 2022 | 110.00K | $304.00K | Reduce |
| Q3 2022 | 143.36K | $634.00K | Add |
| Q4 2022 | 41.62K | $68 | Reduce |
| Q1 2023 | 11.23K | $37 | Reduce |
| Q2 2023 | 137.59K | $283.45K | Add |
| Q3 2023 | 175.50K | $35.12K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.